Global Disposable Endoscopes Market to Reach USD 2.67 Billion by 2030 | MarketsandMarkets™

Strong demand from hospitals and surgical centers, rising chronic disease prevalence, and rapid innovation in imaging technologies accelerate global adoption

Delray Beach, FL, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The global disposable endoscopes market is projected to reach USD 2.67 billion by 2030, growing from USD 0.95 billion in 2025, at a CAGR of 22.9% during the forecast period. This surge is driven by the worldwide shift toward minimally invasive surgeries, rising demand for infection-free clinical workflows, and advancements in 4K/3D visualization, fluorescence imaging, and ergonomic device design.

Today’s healthcare providers face escalating procedural volumes across pulmonology, gastroenterology, urology, orthopedics, and ENT—intensifying the need for single-use endoscopes that enhance patient safety, eliminate reprocessing, and improve operational efficiency. Hospitals and ambulatory surgical centers are increasingly prioritizing sterility, speed, and bedside readiness, accelerating adoption across clinical settings.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=14518319

What Is Driving Market Growth?
The rise in chronic diseases including cancer, gastrointestinal disorders, respiratory illnesses, and urinary tract conditions is fueling the need for frequent endoscopic interventions. As healthcare systems seek to reduce cross-contamination risks and procedural downtime, disposable endoscopes offer critical value by removing the need for costly sterilization and equipment reprocessing.
Minimally invasive surgery trends are strengthening market momentum, especially in urology, gastroenterology, and pulmonology, where demand for portable, high-quality visualization tools continues to climb. In addition, regulatory support, technological advancement, and improvements in hospital infrastructure across emerging markets present significant expansion opportunities.
However, high per-procedure costs, strict regulatory pathways, reimbursement constraints, and medical waste concerns continue to challenge broader market penetration—particularly in cost-sensitive regions.

Market Breakdown
By Type — Urology endoscopes lead global demand due to the high incidence of urinary tract disorders and kidney stones. Single-use ureteroscopes are widely preferred by hospitals and clinics for their ability to reduce contamination, eliminate reprocessing, and enhance procedural efficiency.
By Clinical Usage — The surgical usage segment dominates in 2024, driven by growth in minimally invasive procedures and the need to improve patient safety and infection control.
By Application — Gastroenterology is projected to grow the fastest through 2030 as global prevalence of GI disorders continues to rise and endoscopic screenings become more routine.
By End User — Hospitals hold the largest share, while ambulatory surgical centers and mobile endoscopy services are rapidly increasing adoption due to lower infrastructure requirements.
By Region — North America remains the largest and fastest-growing market, supported by advanced healthcare systems, high chronic disease rates, strong regulatory backing, and earlier adoption of next-generation medical technologies.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=14518319

Competitive Landscape & Recent Strategic Moves
The market is consolidated, with Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Boston Scientific Corporation (US), HOYA Corporation (Japan), and Ambu A/S (Denmark) collectively commanding more than 50% of global market share. Competitive strategies include aggressive product development, regulatory approvals, mergers, and global distribution expansion.

Recent milestones include:

June 2025 – Ambu receives expanded FDA 510(k) clearance for the aScope 5 Cysto HD, enabling use in PCNL procedures.
May 2025 – Ambu introduces new blade sizes for the SureSight Connect video laryngoscopy platform.
February 2025 – Ambu secures CE mark expansion for aScope 5 Cysto HD for single-use cysto-nephroscopy.
April 2025 – KARL STORZ launches Slimline C-MAC S single-use video laryngoscope for complex airway management.
January 2025 – KARL STORZ acquires Swiss distributor ANKLIN, strengthening direct sales capability.

Why This Market Matters Now
Rising infection-control priorities, hospital efficiency pressures, and increased patient safety awareness are accelerating the transition from reusable to disposable scopes. The shift is reshaping procurement models, procedural workflows, and capital planning—impacting purchasing decisions across hospitals, ASCs, mobile endoscopy providers, and diagnostic centers worldwide.
For emerging economies, rapid healthcare modernization and investment in advanced technology are creating new demand for cost-efficient, ready-to-use endoscopy solutions.

Industry Outlook
The disposable endoscopes market is positioned for sustained growth supported by:

Expanding surgical volumes and aging population base
Continuous imaging and design innovation
Increasing global awareness of hospital-acquired infection risk
Rising presence of startups offering cost-effective single-use solutions

Leading players including Olympus Corporation, Ambu A/S, Boston Scientific, KARL STORZ, Verathon Inc., Innovex Medical, Hunan Vathin Medical Instrument, GI View, and Uroviu Corporation continue to advance capabilities in imaging, miniaturization, and ergonomics to strengthen global portfolios and market competitiveness.

For more information, Inquire Now!

Discover Connected Healthcare Market Opportunities:
Endoscopy Equipment Market
Flexible Endoscopes Market
Rigid Endoscopes Market
Endoscope Reprocessing Market
Endoscopic Ultrasonography (EUS) Market

Get access to the latest updates on Top Companies in Disposable Endoscopes and Disposable Endoscopes Market Size

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445,
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: www.marketsandmarkets.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.